High-dose chemotherapy followed by autologous stem cell transplantation for relapsed/refractory primary mediastinal large B-cell lymphoma

被引：38

作者：

Aoki, T. ^{[1
,2
]}

Shimada, K. ^{[2
]}

Suzuki, R. ^{[3
]}

Izutsu, K. ^{[4
]}

Tomita, A. ^{[2
]}

Maeda, Y. ^{[5
]}

Takizawa, J. ^{[6
]}

Mitani, K. ^{[7
]}

Igarashi, T. ^{[8
]}

Sakai, K. ^{[9
,10
]}

Miyazaki, K. ^{[11
]}

Mihara, K. ^{[12
]}

Ohmachi, K. ^{[13
]}

Nakamura, N. ^{[14
]}

Takasaki, H. ^{[15
]}

Kiyoi, H. ^{[2
]}

Nakamura, S. ^{[16
,17
]}

Kinoshita, T. ^{[18
]}

Ogura, M. ^{[1
,19
]}

机构：

[1] Nagoya Daini Red Cross Hosp, Dept Hematol & Oncol, Nagoya, Aichi, Japan

[2] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan

[3] Shimane Univ Hosp, Canc Ctr, Izumo, Shimane, Japan

[4] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan

[5] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan

[6] Niigata Univ, Fac Med, Dept Hematol Endocrinol & Metab, Niigata, Japan

[7] Dokkyo Med Univ, Sch Med, Dept Hematol & Oncol, Mibu, Tochigi, Japan

[8] Gunma Canc Ctr, Dept Hematol & Oncol, Ota, Japan

[9] Shinshu Univ, Sch Med, Dept Biomed Lab Sci, Matsumoto, Nagano 390, Japan

[10] Shinshu Univ, Sch Med, Dept Hematol, Matsumoto, Nagano 390, Japan

[11] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 514, Japan

[12] Hiroshima Univ Hosp, Dept Hematol, Hiroshima, Japan

[13] Tokai Univ, Dept Hematol, Isehara, Kanagawa, Japan

[14] Tokai Univ, Dept Pathol, Isehara, Kanagawa, Japan

[15] Kanagawa Canc Ctr, Dept Med Oncol, 1-1-2 Nakao, Yokohama, Kanagawa 2410815, Japan

[16] Nagoya Univ Hosp, Dept Pathol, Nagoya, Aichi, Japan

[17] Nagoya Univ Hosp, Clin Labs, Nagoya, Aichi, Japan

[18] Aichi Canc Ctr, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan

[19] Tokai Cent Hosp, Dept Hematol, Kakamigahara, Japan

来源：

BLOOD CANCER JOURNAL | 2015年 / 5卷

关键词：

RITUXIMAB; THERAPY;

D O I：

10.1038/bcj.2015.101

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：e372 / e372

页数：5

共 50 条

[11] Autologous Stem Cell Transplantation after Nivolumab Treatment for Patients with Relapsed/refractory Primary Mediastinal B-cell Lymphoma
Smykova, Olesya
Lepik, Kirill
Mikhailova, Natalia
Kozlov, Andrey
Kondakova, Elena
Zalyalov, Yuri
Stelmakh, Lilia
Afanasyev, Boris
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 521 - 521
[12] Primary mediastinal large B-cell lymphoma: role of autologous stem cell transplantation
Cobo, T
De Paz, R
Canales, M
Martin, M
Lopez, A
Hernandez, D
Garcia-Bustos, J
Hernandez-Navarro, F
BONE MARROW TRANSPLANTATION, 2004, 33 : S352 - S352
[13] High dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma.
Holland, D. W.
Engelhardt, B. G.
Goodman, S. A.
Greer, J. P.
Morgan, D. S.
Schuening, F. G.
Wolff, S.
Bitting, R.
Sulur, P.
Stein, R. S.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 434S - 434S
[14] Outcome of primary refractory Hodgkin lymphoma with high-dose chemotherapy and autologous stem cell transplantation
Akhtar, S
El Weshi, A
Rahal, M
Abdelsalam, M
Janabi, L
Hussaini, H
Maghfoor, I
BONE MARROW TRANSPLANTATION, 2006, 37 : S239 - S239
[15] High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: Mediastinal localization predicts for a favorable outcome
Popat, U
Przepiork, D
Champlin, R
Pugh, W
Amin, K
Mehra, R
Rodriguez, J
Giralt, S
Romaguera, J
Rodriguez, A
Preti, A
Andersson, B
Khouri, I
Claxton, D
de Lima, M
Donato, M
Anderlini, P
Gajewski, J
Cabanillas, F
van Besien, K
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 63 - 69
[16] Outcomes of salvage chemotherapy and autologous stem cell transplantation for relapsed or refractory primary mediastinal large B cell lymphoma (PMLCL) are inferior to diffuse large B cell lymphoma (DLBCL).
Kuruvilla, J
Nagy, T
Pintilie, M
Keating, A
Crump, M
BLOOD, 2005, 106 (11) : 590A - 590A
[17] High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Elderly Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma: A Nationwide Retrospective Study
Chihara, Dai
Izutsu, Koji
Kondo, Eisei
Sakai, Rika
Mizuta, Shuichi
Yokoyama, Kenji
Kaneko, Hiroto
Kato, Koji
Hasegawa, Yuichi
Choul, Takaaki
Sugaharall, Hiroyuki
Henzan, Hideho
Sakamaki, Hisashi
Suzuki, Ritsuro
Suzumiya, Junji
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (05) : 684 - 689
[18] Cure of a patient with profoundly chemotherapy-refractory primary mediastinal large B-cell lymphoma: Role of rituximab, high-dose therapy, and allogeneic stem cell transplantation
Nath, SV
Seymour, JF
LEUKEMIA & LYMPHOMA, 2005, 46 (07) : 1075 - 1079
[19] Brazilian Experience Using High-Dose Sequential Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma
Duarte, Bruno K. L.
Valente, Isabella
Vigorito, Afonso C.
Aranha, Francisco J. P.
Oliveira-Duarte, Gislaine
Miranda, Eliana C. M.
Lorand-Metze, Irene
Pagnano, Katia B.
Delamain, Marcia
Marques Junior, Jose F.
Brandalise, Silvia R.
Nucci, Marcio
De Souza, Carmino A.
CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (06): : 449 - 454
[20] High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma
Park, Kwonoh
Yoon, Dok Hyun
Kim, Shin
Park, Chan-Sik
Huh, Jooryung
Lee, Sang-Wook
Suh, Cheolwon
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 256 - 262

← 1 2 3 4 5 →